Double Blind Controlled Trial of Nigral Grafting in Pd

Agency: National Institute of Health (NIH)
Institute: National Institute of Neurological Disorders and Stroke (NINDS)
Type: Research Project (R01)
Project #: 5R01NS033772-02
Application #: 2037900
Study Section: Neurological Disorders Program Project Review B Committee (NSPB)


NIH 2003 R01 NS	Double-Blind Controlled Trial of Nigral Grafting in Pd Olanow, C Warren / Mount Sinai School of Medicine	$428,986
NIH 2002 R01 NS	Double-Blind Controlled Trial of Nigral Grafting in Pd Olanow, C Warren / Mount Sinai School of Medicine	$426,327
NIH 2001 R01 NS	Double-Blind Controlled Trial of Nigral Grafting in Pd Olanow, C Warren / Mount Sinai School of Medicine	$1,048,488
NIH 2000 R01 NS	Double-Blind Controlled Trial of Nigral Grafting in Pd Olanow, C Warren / Mount Sinai School of Medicine	$612,649
NIH 2000 R01 NS	Double-Blind Controlled Trial of Nigral Grafting in Park Olanow, C Warren / Mount Sinai School of Medicine	$50,000
NIH 1999 R01 NS	Double-Blind Controlled Trial of Nigral Grafting in Park Olanow, C Warren / Mount Sinai School of Medicine
NIH 1998 R01 NS	Double Blind Controlled Trial of Nigral Grafting in Pd Olanow, C Warren / Mount Sinai School of Medicine
NIH 1997 R01 NS	Double Blind Controlled Trial of Nigral Grafting in Pd Olanow, C Warren / Mount Sinai School of Medicine
NIH 1996 R01 NS	Double Blind Controlled Trial of Nigral Grafting in Pd Olanow, C Warren / Mount Sinai School of Medicine
NIH 1995 R01 NS	Double Blind Controlled Trial of Nigral Grafting in Pd Olanow, C Warren / Mount Sinai School of Medicine

McNaught, Kevin St P; Belizaire, Roger; Isacson, Ole et al. (2003) Altered proteasomal function in sporadic Parkinson's disease. Exp Neurol 179:38-46

McNaught, Kevin St P; Olanow, C Warren (2003) Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease. Ann Neurol 53 Suppl 3:S73-84; discussion S84-6

McNaught, Kevin St P; Belizaire, Roger; Jenner, Peter et al. (2002) Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. Neurosci Lett 326:155-8

Sealfon, S C; Olanow, C W (2000) Dopamine receptors: from structure to behavior. Trends Neurosci 23:S34-40

Olanow, W; Schapira, A H; Rascol, O (2000) Continuous dopamine-receptor stimulation in early Parkinson's disease. Trends Neurosci 23:S117-26

Tagliati, M; Perl, D P; Drayer, B et al. (2000) Progressive dementia and gait disorder in a 78 year old woman. J Neurol Neurosurg Psychiatry 68:526-31

Freeman, T B; Vawter, D E; Leaverton, P E et al. (1999) Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N Engl J Med 341:988-92